Network Pharmacology, Molecular Docking and in vivo-based Analysis on the Effects of the MBZM-N-IBT for Arthritis.
Alok Kumar MoharanaMahendra GaurTapas K MohapatraRudra Narayan DashBharat Bhusan SubudhiPublished in: Current computer-aided drug design (2024)
In conclusion, MBZM-N-IBT is safe at 50 mg/kg and can manage arthritis independent of CHIKV infection through modulation of multiple pathways and arthritis-associated targets.